Global Saliva Collection & Diagnostics Market is expected to have a market value of USD 5,470.08 Million by 2027.
Saliva is a translational research tool and diagnostic medium utilized as a part of novel approaches to give molecular biomarkers a variety of oral and systemic infections and conditions. The capacity to break down saliva to screen health conditions and diseases is an exceedingly alluring objective for oral health advancement and research. Saliva tests have been used to detect cancer risk, periodontitis, breast cancer, oral cancer, salivary gland diseases, and systemic disorders such as hepatitis and HIV.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3570
Over the years, major market players in the embolization particle focus on various growth strategies such as product launches, product advancements, and expansions to cater to the growing needs. For instance, in May 2020, the Food and Drug Administration granted emergency authorization for the first at-home saliva collection kit to test for the coronavirus. The test kit was developed by a Rutgers University laboratory, called RUCDR Infinite Biologics, in partnership with Spectrum Solutions and Accurate Diagnostic Labs.
The global saliva collection & diagnostics market is segmented based on site of collection, application, and end user. The global saliva collection & diagnostics market based on the site of collection has been segmented into parotid gland collection, submandibular/sublingual gland collection, minor salivary glands collection, and others. The global saliva collection & diagnostics market, by application, has been segmented into disease diagnosis, forensics, pharmaceutical and biotechnology companies, and others. The global saliva collection & diagnostics market, by end user, is divided into hospitals & dental clinics, diagnostic centers, investigation laboratories, and others.
The global saliva collection & diagnostics market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas region spearheaded the saliva collection and diagnostics market in 2019. The market in the Americas is further segmented into North America and Latin America. The North American saliva collection and diagnostics market is bifurcated into the US and Canada. North America is expected to dominate the market with the largest share, mainly due to the increasing geriatric population and the availability of advanced healthcare facilities.
The European saliva collection and diagnostics market has been further segmented into Western Europe and Eastern Europe. The Western Europe saliva collection & diagnostics market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The increasing presence of major companies in the European countries acts as a significant factor for the growth of the saliva collection and diagnostic market. SARSTEDT AG & Co. KG (Germany) has a presence in 36 countries in the Europe region.
The saliva collection diagnostics market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. Asia-Pacific is expected to be the fastest-growing market mainly due to increasing funding for R&D, developing healthcare infrastructure, government initiatives and support to improve public health, and huge investment by companies.
The Middle East & Africa saliva collection & diagnostics market is segmented into the Middle East and Africa. Over the last few years, the Middle East and Africa saliva collection and diagnostic market is growing dramatically due to the increasing prevalence of various infectious diseases.
MRFR recognizes the following companies as the Key Players in the Global Saliva Collection & Diagnostics Market— OraSure Technologies, Inc. (US), Neogen Corporation (US), Salimetrics, LLC (US), SARSTEDT AG & CO. KG (Germany), Oasis Diagnostics Corporation (US), Filtration Group Corporation (US), Quest Diagnostics Incorporated (US), Tecan Group Ltd (Switzerland), and Abbott Laboratories (US).